Henney J E
Commissioner Of Food And Drugs, Food And Drug Administration, Rockville, Maryland 20857, USA.
J Med Internet Res. 2001 Jan-Mar;3(1):E3. doi: 10.2196/jmir.3.1.e3.
The sale of consumer products over the Internet has grown rapidly, including the sale of drugs. While the growth in online drug sales by reputable pharmacies is a trend that may provide benefits to consumers, online drug sales also present risks to purchasers and some unique challenges to regulators, law enforcement officials and policy makers. The Food and Drug Administration (FDA or the Agency) is concerned about the public health implications of Internet drug sales, and we are responding to these concerns as part of our overall goal of developing and implementing risk-based strategies to protect public health and safety. Although other products regulated by the Agency, such as medical devices, medical test products, foods, dietary supplements and animal drugs also are sold online, this paper focuses on online drug sales. We discuss the advantages and risks of online drug sales, outline FDA's authority and enforcement activities in this area, and describe new initiatives we are taking to better respond to the regulatory challenges we face.
通过互联网销售消费品的规模增长迅速,其中包括药品销售。虽然信誉良好的药店开展的在线药品销售增长这一趋势可能会给消费者带来益处,但在线药品销售也给购买者带来风险,给监管机构、执法官员和政策制定者带来一些独特的挑战。美国食品药品监督管理局(FDA或该机构)关注互联网药品销售对公众健康的影响,作为我们制定和实施基于风险的战略以保护公众健康和安全这一总体目标的一部分,我们正在应对这些问题。尽管该机构监管的其他产品,如医疗器械、医学检测产品、食品、膳食补充剂和动物药品也在网上销售,但本文重点关注在线药品销售。我们讨论了在线药品销售的优势和风险,概述了FDA在这一领域的权限和执法活动,并描述了我们为更好应对所面临的监管挑战而采取的新举措。